Table 3.
Subgroup analysis according to indication to biopsy (parenchymal disease versus focal lesion).
| Variable | Subgroup | GROUP 1 EUS-Guided Liver Biopsy (54 pts) |
GROUP 2 Percutaneous Liver Biopsy (62 pts) |
p Value |
|---|---|---|---|---|
| Total length of specimen (mm) | Parenchymal disease | 21.5 (14.1–25.4) | 30.2 (23–34) | 0.008 |
| Focal lesion | 10 (8.9–21.3) | 15 (11.3–25.8) | 0.03 | |
| No. of complete portal tracts | Parenchymal disease | 18.5 (10–23.2) | 21 (11–24) | 0.09 |
| Focal lesion | -- | -- | -- | |
| Diagnostic adequacy | Parenchymal disease | 26 (96.2%) | 31 (100%) | 0.88 |
| Focal lesion | 25 (92.2%) | 31 (100%) | 0.79 | |
| Diagnostic accuracy | Parenchymal disease | - | -- | -- |
| Focal lesion | 24 (88.8%) | 31 (100%) | 0.82 | |
| Procedural duration (mins) | Parenchymal disease | 7 (5–10) | 1 (1–3) | <0.001 |
| Focal lesion | 7 (5–12) | 1 (1–4) | <0.001 |
Values are expressed as number (percentage) in the case of categorical outcomes or median (interquartile ranges) in the case of continuous variables; Abbreviations: EUS, Endoscopic Ultrasound. The bold indicates results with statistical significance.